Company sells common stock, convertible debentures, two-year warrants
By Devika Patel
Knoxville, Tenn., Sept. 6 – Abba Medix Group Inc. said it raised C$6.03 million in a private placement of units.
The deal was conducted on a best-efforts basis in connection with the company’s previously announced planned acquisition of Marijuana for Trauma Inc. and the Longevity Project and priced for between C$6 million and C$10 million on June 30.
The company sold 19,001,000 equity units of one common share and one warrant at C$0.25 per unit.
Abba also sold 1,275 debt units of one 8.5% secured debenture and 1,000 warrants at C$1,000 per unit.
The warrants will be exercisable at C$0.40 for two years. The strike price is a 42.86% premium to the June 4 closing share price of C$0.28.
Mackie Research Capital Corp. was the agent.
Proceeds will be used for the acquisition, working capital and general corporate purposes.
The medical marijuana company is based in Toronto.
Issuer: | Abba Medix Group Inc.
|
Issue: | Units of one common share and one warrant, units of an 8.5% secured debenture and 1,000 warrants
|
Amount: | C$6,025,250
|
Warrant expiration: | Two years
|
Warrant strike price: | C$0.40
|
Agent: | Mackie Research Capital Corp.
|
Pricing date: | June 30
|
Settlement date: | Sept. 6
|
Stock symbol: | CSE: ABA
|
Stock price: | C$0.28 at close June 4
|
|
Equity units
|
Amount: | C$4,750,250
|
Units: | 19,001,000
|
Price: | C$0.25
|
Warrants: | One warrant per unit
|
|
Debt units
|
Amount: | C$1,275,000
|
Units: | 1,275
|
Price: | C$1,000
|
Coupon: | 8.5%
|
Warrants: | 1,000 warrants per unit
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.